Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease

• Titel: Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease
• Titelzusatz: a cohort study across 18 countries
• Mitwirkende: Al-Ali, Amein K. [VerfasserIn]
• Mitwirkende: Merle, Uta [VerfasserIn]
• Verf.angabe: The CAPACITY-COVID Collaborative Consortium and LEOSS Study Group*
• E-Jahr: 2022
• Jahr: 14 March 2022
• Umfang: 7 S.
• Fussnoten: Online ahead-of-print veröffentlicht 4 November 2021 ; *The CAPACITY-COVID Collaborative Consortium and LEOSS Study Group: Al-Ali AK, Merle U [und viele weitere Personen] ; Gesehen am 02.02.2023
• Titel Quelle: Enthalten in: European heart journal
• Ort Quelle: Oxford : Oxford University Press, 1980
• Jahr Quelle: 2022
• Band/Heft Quelle: 43(2022), 11 vom: März, Seite 1104-1120
• ISSN Quelle: 1522-9645
• DOI: doi:10.1093/eurheartj/ehab656
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1833053591

Abstract

Patients with cardiac disease are considered high risk for poor outcomes following hospitalization with COVID-19. The primary aim of this study was to evaluate heterogeneity in associations between various heart disease subtypes and in-hospital mortality.We used data from the CAPACITY-COVID registry and LEOSS study. Multivariable Poisson regression models were fitted to assess the association between different types of pre-existing heart disease and in-hospital mortality. A total of 16 511 patients with COVID-19 were included (21.1% aged 66-75 years; 40.2% female) and 31.5% had a history of heart disease. Patients with heart disease were older, predominantly male, and often had other comorbid conditions when compared with those without. Mortality was higher in patients with cardiac disease (29.7%; n = 1545 vs. 15.9%; n = 1797). However, following multivariable adjustment, this difference was not significant [adjusted risk ratio (aRR) 1.08, 95% confidence interval (CI) 1.02-1.15; P = 0.12 (corrected for multiple testing)]. Associations with in-hospital mortality by heart disease subtypes differed considerably, with the strongest association for heart failure (aRR 1.19, 95% CI 1.10-1.30; P < 0.018) particularly for severe (New York Heart Association class III/IV) heart failure (aRR 1.41, 95% CI 1.20-1.64; P < 0.018). None of the other heart disease subtypes, including ischaemic heart disease, remained significant after multivariable adjustment. Serious cardiac complications were diagnosed in <1% of patients.Considerable heterogeneity exists in the strength of association between heart disease subtypes and in-hospital mortality. Of all patients with heart disease, those with heart failure are at greatest risk of death when hospitalized with COVID-19. Serious cardiac complications are rare during hospitalization.